Mesoblast Limited (MESO)

Trade MESO now with
3/29/2021 8:15:26 AM Mesoblast Names Philip Facchina To Board
1/11/2021 10:19:32 AM Stock Alert: Mesoblast Jumps 40%
12/2/2020 6:15:19 AM Mesoblast: FDA Grants Fast Track Designation For Remestemcel-L For ARDS Due To COVID-19
11/11/2020 6:07:24 AM Mesoblast: Second Interim Analysis Of Outcomes Results In Recommendation To Continue Remestemcel-L Phase 3 Trial
10/13/2020 6:03:46 AM Mesoblast Says Phase 3 Trial Of Remestemcel-L Surpassed 50% Enrollment
9/2/2020 6:10:13 AM Mesoblast Secures Ethics Approval To Treat COVID-19 Patients In Australia